Immunovant, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Annual reports show investors how a company performed financially over a full year.
Earnings announcements let investors know if the company made or lost money recently.
Quarterly reports help investors track company performance throughout the year.
Quarterly earnings updates show investors how the company is doing between annual reports.
Stocky reads Immunovant, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Immunovant, Inc.'s most recent tracked filing was a 10-K on 20 May 2026: Files annual report for fiscal year ended March 31, 2026.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.